Global Perspectives on New Data in Type 2 Diabetes — Congress-to-Clinic Insights From ADA and EASD 2025
53 mins; October 21, 2025
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
28 mins; October 20, 2025
Diagnosing and Treating IBS: It Begins With One Simple Question
61 hours 30 mins; October 19, 2025
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
59 mins; October 14, 2025
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
9 mins; October 02, 2025
Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
0 secs; October 02, 2025
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
34 mins; October 01, 2025
New Insights in the Management of HCM: Exploring the Clinical Spectrum
32 mins; October 01, 2025
Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection Fraction
15 mins; September 30, 2025
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
4 mins; September 29, 2025
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
5 mins; September 29, 2025
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers
5 mins; September 29, 2025
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
4 mins; September 29, 2025
Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
4 mins; September 25, 2025
Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
4 mins; September 25, 2025
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
4 mins; September 25, 2025
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
5 mins; September 25, 2025
From Resistance to Response: Evolving Strategies in MDD Management
57 mins; September 25, 2025
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC
4 mins; September 25, 2025
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC
5 mins; September 25, 2025
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
5 mins; September 23, 2025
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
5 mins; September 23, 2025
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
4 mins; September 23, 2025
Potassium Binders in Practice: Clinical Trial Evidence
6 mins; September 23, 2025
Potassium Binders: Safety Comes First!
7 mins; September 23, 2025
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
7 mins; September 23, 2025
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
5 mins; September 23, 2025
Future Directions in Managing Hyperkalemia in CKD and HF
7 mins; September 23, 2025
The Critical Interplay: CKD, HF, and HyperkaleAmia
4 mins; September 23, 2025
Treatment Revolution in IgA Nephropathy
14 mins; September 23, 2025
Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
11 mins; September 23, 2025
Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
53 mins; September 18, 2025
Anatomical Outcomes from the LIGHTSITE III Trial
5 mins; September 15, 2025
Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection
4 mins; September 15, 2025
Clinical and Safety Outcomes from the LIGHTSITE III Trial
6 mins; September 15, 2025
Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape
9 mins; September 15, 2025
Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice
9 mins; September 15, 2025
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
6 mins; September 15, 2025
Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications
6 mins; September 15, 2025
Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
5 mins; September 15, 2025
Psoriasis and Obesity: Going Pound for Pound on Comprehensive, Patient-Centered Management
58 mins; September 14, 2025
Collaborative Care for CRSwNP Expert and Patient Insights
60 hours 0 mins; September 11, 2025
CETP Inhibition With Obicetrapib: Implications for Cardiovascular Event Prevention
4 mins; September 01, 2025
Insights and Updates: New Data on Next-Generation Retinal Treatments
29 mins; September 01, 2025
Retina Case Review: Translating the Data Into Care
14 mins; September 01, 2025
Global Perspectives on Perioperative Immunotherapy in LA HNSCC
16 mins; August 28, 2025
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
55 mins; August 27, 2025
The Clinical Weight of TTR: What the Latest Data Reveal
13 mins; August 27, 2025
Optimizing IgAN Care: Achieving Lower Proteinuria Targets with Combination Therapy
14 mins; August 26, 2025
Applying Perioperative ICIs in Clinical Practice
5 mins; August 21, 2025
Emerging Evidence for Perioperative ICIs in Locally Advanced HNSCC
5 mins; August 21, 2025
Managing Immune-Related Adverse Events in the Perioperative Setting
